system and computerprogramprodukt automatic distinction between atrial fibrillation and very rare *: atrial fibrillation

• 1. 网络组件，这种网络组件的操作方法，具有这种网络组件的自动化系统，用这种网络组件在自动化系统中传输数据的方法和相应的计算机程序及计算机程序产品 [P] . 中国专利： CN101627580A . 2010-01-13
• 2. 用于感知系统的自动配置系统、用于运行自动配置系统的方法、具有感知系统的自主系统以及计算机程序产品 [P] . 中国专利： CN111771170A . 2020-10-13
• 3. Method for producing atrial fibrillation model animal, method for inducing atrial fibrillation, and method for evaluating atrial fibrillation inhibitor using animal inducing atrial fibrillation [P] . 日本专利： JP4704712B2 . 2011-06-22

  机译： 房颤模型动物的生产方法，房颤的诱导方法和利用动物房颤的评价房颤抑制剂的方法

• 4. Atrial fibrillation analyzer, atrial fibrillation analysis system, atrial fibrillation analysis method, and program [P] . 美国专利： US9504400B2 . 2016-11-29

  机译： 房颤分析仪，房颤分析系统，房颤分析方法和程序

• 5. ATRIAL FIBRILLATION ANALYZER, ATRIAL FIBRILLATION ANALYSIS SYSTEM, ATRIAL FIBRILLATION ANALYSIS METHOD, AND PROGRAM [P] . 美国专利： US2014257123A1 . 2014-09-11

  机译： 房颤分析仪，房颤分析系统，房颤分析方法和程序

• 1. Left atrial enlargement and non-paroxysmal atrial fibrillation as risk factors for left atrial thrombus/spontaneous Echo contrast in patients with atrial fibrillation and low CHA2DS2-VASc score [J] . Wei-Dong LIN, Yu-Mei XUE, Fang-Zhou LIU, 老年心脏病学杂志（英文版） . 2020,第003期
• 2. Detection of ST-2 and TGF-β2 levels in patients with atrial fibrillation and their correlation with atrial fibrillation remodeling [J] . Xiang-Wen Hu, Chen Mo, Qing-Mei Xu, 海南医科大学学报（英文版） . 2021,第013期
• 3. Detection of ST-2 and TGF-β2 levels in patients with atrial fibrillation and their correlation with atrial fibrillation remodeling [J] . Xiang-Wen Hu, Chen Mo, Qing-Mei Xu, 海南医科大学学报(英文版) . 2021,第013期
• 4. Relevance of electrical remodeling in human atrial fibrillation: results of the asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial mechanisms of atrial fibrillation study. [J] . Jeff S Healey, Carsten W Israel, Stuart J Connolly, Circulation. Arrhythmia and electrophysiology . 2012,第4期
• 5. Response to Letter Regarding Article, "Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R(2)CHADS(2) Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts" [J] . Piccini Jonathan P., Stevens Susanna R., Chang YuChiao, Circulation: An Official Journal of the American Heart Association . 2013,第11期
• 6. Letter by Apostolakis et al Regarding Article, "Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R(2)CHADS(2) Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts" [J] . Apostolakis Stavros, Lane Deirdre A., Banerjee Amitava Circulation: An Official Journal of the American Heart Association . 2013,第11期
• 7. Impact of three dimensional atrial fibrosis on development and stability of rotational and focal sources in atrial fibrillation — A 3D simulation and clinical high-density mapping study in persistent atrial fibrillation [C] . Markus Rottmann, Viktor Markstein, Ufuk Arslan, Computing in Cardiology Conference . 2016
• 8. Cardiac ablation as the initial therapy for symptomatic atrial fibrillation results in less recurrance of atrial fibrillation when compared to antiarrhythmic therapy [D] . Mikhli, Erica 2011
• 9. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection In Patients With Atrial Fibrillation) trial [O] . Gaurav Mohan, Naved Aslam, Gurpreet Singh Wander 2013
• 10. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection In Patients With Atrial Fibrillation) trial Vivek Y.ReddyShephal K.DoshiHorstSievertMauriceBuchbinderPetrNeuzilKennethHuberJonathan L.HalperinDavidHolmeson behalf of the PROTECT AF InvestigatorPercutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection In Patients With Atrial Fibrillation) trialCirculation1272013720729 [O] . Mohan Gaurav, Aslam Naved, Wander Gurpreet Singh 2013

• 1. The Relation of Atrial Fibrillation and Inflammation Do Inflammation Imply the Pathogenesis of Atrial Fibrillation? [J] . 傅锐斌 ,吴平生 ,吴书林 . 岭南心血管病杂志：英文版 . 2008,第2期
• 2. Minimally invasive thoracoscopic left atrial appendage occlusion compared with transcatheter left atrial appendage closure for stroke prevention in recurrent nonvalvular atrial fibrillation patients after radiofrequency ablation:a prospective cohort study [J] . Jian-Long WANG ,Kuo ZHOU ,Zheng QIN . 老年心脏病学杂志:英文版 . 2021,第11期
• 3. 心房颤动临床诊断误区分析 [C] . 李卫东 . 2015临床急症经验交流高峰论坛 . 2015
• 4. TNNI3基因罕见变异与中国汉族人群心房颤动的分子遗传学分析 [A] . 王楚楚 . 2015